Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
about
Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experimentsHeart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.Inflammatory processes in cardiovascular disease: a route to targeted therapies.New directions for pharmacotherapy in the treatment of acute coronary syndrome.Imaging atherosclerosis with positron emission tomography.Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.Infectious Complications and Immune/Inflammatory Response in Cardiogenic Shock Patients: A Prospective Observational Study.LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction?Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.Profiling the Evolution of Inflammatory Response and Exploring Its Prognostic Significance in Acute Myocardial Infarction: The First Step to Establishing Anti-Inflammatory Strategy.Losmapimod does not reduce cardiovascular events in patients with acute myocardial infarction.Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.TAB1-induced auto-activation of p38α mitogen-activated protein kinase is crucially dependent on Threonine 185.Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.Unraveling Vascular Inflammation: From Immunology to Imaging.Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization.Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments.Non-Invasive Immuno-Metabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance.Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease.Inflammation in Cardiovascular Disease.Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.p38α: A Profibrotic Signaling Nexus.Flawed Reasoning Allows the Persistence of Mainstream Atherothrombosis Theory.Molecular Imaging of Atherosclerosis: A Clinical Focus.SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1.The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4)
P2860
Q37329529-CBF1273D-903F-464D-981A-F66523D9EEB2Q38630188-1210E61A-B303-4A18-86EF-2640ECB30587Q38654054-39FE41DF-121F-4ED4-A729-391A6DAAACB3Q38786058-88FAFCF2-2563-4466-80E5-335578B71690Q38788685-F300A528-8246-4812-A0A2-38C3888411D7Q38817144-79D395E9-17D3-4321-A72A-995878D110B8Q38820272-9F0C237B-EF86-4930-9B00-DCEDD294510EQ38845570-07D0D574-2D9B-431C-9527-8E671D79FAEBQ38880162-63137980-0CCA-4173-831E-CF76B5CDA39DQ39268068-F565C593-B3C9-46DB-8F12-15B833B7E7AAQ39293450-51F3F930-C35A-43DA-9AAA-756B1F6094A1Q40503940-CA66E178-15A8-4D1C-967C-A20B5CD7D022Q41428927-95777E7D-F661-4BBA-BC45-DA2CE360A7F0Q41728608-A55CBE47-4C75-4522-87AB-39A02AEF657AQ42363192-D24912E5-DF36-4D4D-8E1F-CFF4056D8D9DQ42384664-F2D0FECA-D5D9-4782-909E-6DD580BB257CQ45073053-EA8FE5F6-13DB-464C-BAEF-27B1763D950DQ46724260-95A53376-CDA8-4761-AABD-72A33E3778B2Q47106217-8973894B-76A9-4496-92DA-2F119DF0D8E5Q47305269-B6548AB1-C6BB-48BE-953C-88940501E654Q47599422-1E6B49A0-FB07-4B10-8361-041BC4A6D454Q47960412-521E21A8-E112-4473-917C-563061051F57Q49340076-07385D92-7BB5-4958-8FC8-C31C73C4ABA7Q49359559-00F0205B-EECF-4D07-B284-D12E8715D672Q50027672-31FC48FD-84B7-46D2-BABD-51B09161F6A9Q50094089-91559E31-7C4D-4FA5-9973-2A739B232CB9Q53108992-ADBEA891-5C84-4A93-BE3F-F81BA32AE28DQ53609113-2288D2FF-EA40-4766-859D-999B88858870Q53723126-2CE52A0C-2851-40EF-AD13-75A50E86090DQ54936139-5727FEA4-E4AD-45BB-A687-FD00940C3569Q54967787-47CC1C45-7243-4291-806A-3B97DBFDB890Q54978312-321D6F7A-883D-43E7-8F2E-97F701183CA9Q58592667-A35B5F99-EC6F-4EE3-8628-EAA787D37CBA
P2860
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of Losmapimod on Cardio ...... : A Randomized Clinical Trial.
@en
type
label
Effect of Losmapimod on Cardio ...... : A Randomized Clinical Trial.
@en
altLabel
Effect of Losmapimod on Cardio ...... n: A Randomized Clinical Trial
@en
prefLabel
Effect of Losmapimod on Cardio ...... : A Randomized Clinical Trial.
@en
P2093
P921
P356
P1476
Effect of Losmapimod on Cardio ...... : A Randomized Clinical Trial.
@en
P2093
Alexandr Parkhomenko
Andrzej Budaj
Christian Hamm
David A Morrow
František Kovar
Jean-Francois Tanguay
Jennifer B Shannon
Jindrich Spinar
John J Lepore
P304
P356
10.1001/JAMA.2016.3609
P407
P577
2016-04-04T00:00:00Z